magrolimab,decitabine,cedazuridine
otsuka,gilead,mgi pharma,supergen
['decitabine,cedazuridine', 'magrolimab', 'decitabine', 'mds']
#ash22: #astex reported phase 2 study of oral #decitabine/#cedazuridine in combination with #magrolimab for previously untreated subjects with intermediate to very high-risk #myelodysplasticsyndromes (mds) 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.